People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bicycle Therapeutics Plc | — | Pharmaceuticals | Growth/Late | $555.5M | $7.3B | 2024 |
JOSE-CARLOS J. GUTIERREZ-RAMOS at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JOSE-CARLOS J. GUTIERREZ-RAMOS on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Lee | 1 | 6 |
| FELIX J. BAKER | 1 | 4 |
| PIERRE LEGAULT | 1 | 2 |
| STEPHEN N. SANDS | 1 | 1 |
| NIGEL N. CROCKETT | 1 | 1 |
| NICHOLAS N. KEEN | 1 | 1 |
| SANTIAGO N. ARROYO | 1 | 1 |
| MICHAEL N. HANNAY | 1 | 1 |
| MICHAEL N. SKYNNER | 1 | 1 |
| ALISTAIR N. MILNES | 1 | 1 |
| ALETHIA YOUNG | 1 | 1 |
| JANICE J. BOURQUE | 1 | 1 |
| RICHARD N. KENDER | 1 | 1 |
| GREGORY N. WINTER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.